Investors Frustrated as Sanofi CEO Fails to Make a M&A Deal

For the last year, Sanofi's chief executive has made clear his quest for deals to help revive the fortunes of France's biggest drugmaker.

The market is still waiting. Olivier Brandicourt's failure to land two big biotech acquisitions he was chasing has led to growing impatience among some investors.

"The company needs a growth driver and must make an acquisition. Time is running out," said Olivier David of Vega Investment Managers, who holds shares in the company.

Back to news